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Abstract We previously showed cooperation of leukemia inhib-
itory factor (LIF) and insulin-like growth factor I (IGF-I) dur-
ing development. Mice doubly de¢cient in LIF and IGF-I died
at birth. We now analyze the possible combined in£uence of
both factors on postnatal growth. The haploinsu⁄ciency of the
Igf-I gene on a Lif null background caused a marked reduction
in body mass index and white adipose tissue only in female mice.
These animals had increased leptin, increased serum IGF-I and
apparent substitution of white adipose tissue by brown adipose
tissue. The complex interrelationships between LIF and IGF-I
in regulating weight thus involve sexually dimorphic e¡ects on
adipose tissue di¡erentiation and circulating leptin.
* 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Leukemia inhibitory factor (LIF) and insulin-like growth
factor I (IGF-I) are members of two protein signaling families
with a broad spectrum of common cellular targets [1,2]. In
adult mice, LIF absence causes a 30% weight reduction [3],
whereas IGF-I absence causes a 70% decrease in growth [4].
In a previous study, we demonstrated cooperation between
LIF and IGF-I to achieve normal fetal growth as well as
lung, bone and muscle development. Indeed, mice doubly de-
¢cient in LIF and IGF-I are growth-retarded and do not
survive after birth [5]. Little is known, however, of the phys-
iological cooperation of LIF and IGF-I in vivo in postnatal
life.
LIF e¡ects on cell proliferation and di¡erentiation are
mediated by a dimeric receptor of the cytokine family that
also includes the growth hormone (GH) and leptin receptors
[6]. Multiple cellular functions are in£uenced by IGF-I
through a well known tyrosine kinase receptor of the insulin
receptor family [2]. Evidence has emerged of cross-talk be-
tween the signal transduction pathways of cytokine receptors
and insulin/IGF-I receptors at several levels [7,8].
Leptin, a hormone secreted mainly by white adipose tissue
(WAT) and also by brown adipose tissue (BAT) [9], is another
major regulator of body weight and energy balance. It was
recently reported that leptin and insulin combine additively to
reduce food intake and body weight in rats [10]. The goal of
the present study was to analyze in vivo the combined impact
of LIF absence (L3=3) and IGF-I haploinsu⁄ciency (Iþ=3) on
postnatal growth and on adipose tissue physiology, to gain
insight into the complexity of sexually dimorphic body weight
control.
2. Materials and methods
2.1. Mouse production, maintenance and growth
The mutant mice for Igf-I and Lif genes were kindly provided by
Drs. Argiris Efstratiadis (Columbia University, NY, USA) and Colin
L. Stewart (National Cancer Institute, Frederick, MD, USA), respec-
tively [3,4]. The generation and genotyping of the double mutant mice
has been described [5]. The original mice were bred on a mixed 129/
svUMF1UC57Bl6/j background. Mice were maintained following es-
tablished animal care recommendations at the Centro de Investiga-
ciones Biolo¤gicas on a 12 h light:dark cycle, were fed ad libitum and
were weaned at 3 weeks. Mice were weighed weekly from postnatal
weeks 3 to 12. Body length (nose to anus) was measured at 8 weeks
and body mass index (BMI, weight/length2) was calculated.
2.2. Serum biochemical parameters and statistical methods
Blood was collected without anesthesia from the orbital plexus,
obtained after overnight fasting. Serum was stored at 320‡C. An
enzymatic assay was used to determine total triacylglycerol (Sigma,
St. Louis, MO, USA). Glucose was measured with a glucometer using
blood glucose strips (Roche Diagnostics, Mannheim, Germany). Se-
rum IGF-I (DSL, Webster, TX, USA) and leptin (Linco, St. Charles,
MO, USA) were measured by radioimmunoassay. Statistical analysis
was performed ¢rst with a one-way ANOVA for multiple compari-
sons, applying Tukey’s correction and then a Student’s t-test for com-
parison of the more signi¢cant phenotypes.
2.3. Northern blot
Total pituitary RNA was extracted with Trizol reagent (Invitrogen,
Gaithersburg, MD, USA) according to the manufacturer’s instruc-
tions. Northern analysis of pituitary GH expression was performed
as described [11,12] using 20 Wg total pituitary RNA/lane. The GH
probe is a 700 kb NdeI fragment of human growth hormone 1 gene
(ATCC, Rockville, MA, USA), the L-actin probe (Mouse DECA-
probe template, Ambion, Austin, TX, USA) is a 1.076 kb fragment
of the mouse cytoplasmic L-actin gene. Probes were labeled by ran-
dom priming with RadPrime DNA Labeling System (Invitrogen).
2.4. Histology
Tissues were ¢xed in 4% paraformaldehyde in phosphate-bu¡ered
saline, dehydrated in ethanol, and para⁄n-embedded. Blocks were
sectioned at 7 Wm and stained with hematoxylin/eosin (HpE) or
with antiserum raised in rabbit (kind gift of Dr. Eduardo Rial,
CIB, CSIC [13]) against uncoupling protein 1 (UCP1).
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3. Results
3.1. Sexually dimorphic postnatal growth retardation
Mutant animal growth curves revealed important di¡eren-
ces between genotypes. Body length was similar regardless of
Lif null mutation or Igf-I haploinsu⁄ciency; only Igf-I null
mice were, as expected, dwarf (data not shown). Weight, in
contrast, was always lower in the L3=3Iþ=3 females than the
rest of animals studied, and weight gain was essentially ar-
rested in them after 6 weeks (Fig. 1A). These females were
thin with marked reduction of perigonadal WAT (Fig. 1A,B),
but appeared otherwise normal; at least some had an estrous
cycle based on cell characteristics of vaginal smears. At 8
weeks, their BMI was lower (P6 0.05) than that of the
L3=3Iþ=þ females (Fig. 1C). The growth curve in male
L3=3Iþ=3 mice was indistinguishable from that of Lif null
and wild type males up to 6 weeks.
3.2. Metabolic parameters and pituitary GH expression
There were no signi¢cant di¡erences in fasting glucose lev-
els at 8 weeks of age in any group. Triglycerides were high in
the Lif null females, but the values were normal in the
L3=3Iþ=3 females. Serum IGF-I concentrations, unexpectedly,
were higher than normal in male and female L3=3Iþ=þ as well
as L3=3Iþ=3 mice, although this was statistically signi¢cant
only in females (Table 1). Both the Lþ=3Iþ=3 and L3=3Iþ=3
mice had slightly increased pituitary GH expression (Fig. 2).
3.3. Increased serum leptin
Compared to wild type mice, leptin tended to increase in
IGF-I haploinsu⁄cient or Lif null animals, in both males and
females, but increased synergistically only in L3=3Iþ=3 fe-
males (3.9 ng/ml in the L3=3Iþ=3 females vs. 2.8 ng/ml in
L3=3Iþ=3 males as well as in L3=3Iþ=þ females) (Fig. 3).
3.4. Decreased WAT in double mutant females
Macroscopic analysis of the perigonadal WAT deposits
showed a marked reduction in L3=3Iþ=3 females (Fig. 1B),
whereas the interscapular BAT deposits were apparently nor-
mal (data not shown). Histologically, the WAT adipocytes
were depleted of lipid droplets and the tissue presented a
very compact morphology (Fig. 4), similar to the BAT of
wild type animals. The BAT substituting normal WAT in
mutant females had high expression of UCP1 (Fig. 5). In
Fig. 1. Postnatal growth curves and phenotypes of adult mice. A: Body weight from weeks 3 to 12, in males and females. Note the arrested
weight gain in the L3=3Iþ=3 females after 6 weeks. Genotypes and number of animals (in parentheses) are shown. B: Perigonadal adipose tis-
sue of 12 week old female mice. C: BMI of 8 week old mice. *P6 0.05, by Student’s t-test.
Table 1
Comparison of metabolic parameters at 8 weeks
Genotype Females Males
Lif Igf-I +/+ +/+ +/+ +/3 3/3 +/+ 3/3 +/3 +/+ +/+ +/+ +/3 3/3 +/+ 3/3 +/3
Glucose 63.1T 6.7 57.5T 8.7 49.2T 4.1 56.2T 6.7 47.7T 10.7 49.4T 6.1 44.08T 5.5 57.2T 7.5
(n) (14) (13) (9) (14) (8) (11) (12) (9)
Triglycerides 53.9T 6.7 60.6T 2.3 82.1T 7.2* 60T 3.1 85.4T 12.2 77.4T 6.7 65.02T 2.9 55.8T 1.9
(n) (7) (7) (7) (7) (7) (5) (6) (3)
IGF-I 478T 58.8 470T 53.4 832.1T 113* 718.7T 57.7* 506.11T 35.5 426.2T 32.5 642.1T 58.7 655.5T 84.9
(n) (10) (5) (7) (16) (9) (4) (7) (10)
Glucose and triglyceride concentrations are given in mg/dl and IGF-I concentration is in ng/ml.
MeanTS.E.M. is shown. A one-way ANOVA test was performed initially; *P6 0.05, by Student’s t-test with respect to wild type animals.
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L3=3Lþ=þ males there was a partial substitution of the WAT
by BAT, although surprisingly this phenotype was largely
rescued in the L3=3Iþ=3 males (Figs. 4 and 5).
4. Discussion
The network of factors in£uencing adipose tissue di¡eren-
tiation, metabolism and body mass in mammals is complex
and sexually dimorphic. The multifunctional, highly glycosy-
lated cytokine LIF is unusual in this context, as both LIF
overexpression [14] and LIF de¢ciency [3] cause decreased
body weight. It therefore appears critical for adequate weight
control to maintain normal LIF levels, which act in endocrine
and paracrine modes in the periphery, as well as in the central
nervous system [1,10]. Indeed, central LIF gene therapy in
rats has been shown to suppress food intake, body weight
and induce a decrease in leptin and insulin [15]. The less
understood decreased growth caused by the absence of LIF
[3] is con¢rmed in the present study, which we show is due to
a decrease in BMI and not to decreased skeletal growth. This
absence of longitudinal growth retardation concurs with the
¢nding that LIF de¢ciency tended to increase serum IGF-I,
even in Igf-I haploinsu⁄cient mice. This was particularly
marked in L3=3Iþ=3 females, with IGF-I values signi¢cantly
above those of wild type mice. Since the mutant mice had
increased pituitary GH mRNA expression, our data support
that LIF de¢ciency causes abnormally high function of the
GH^IGF-I axis, which overcompensates the Igf-I haploinsuf-
¢ciency. This is concordant with the profound in£uence of
LIF in pituitary development. When LIF was overexpressed
locally in pituitary in transgenic mice, it induced a Cushingoid
syndrome with somatotroph and gonadothroph hypoplasia
and low plasma IGF-I [16]. Leptin levels were not reported
in these mice.
The phenotype observed in the adipose tissue therefore ap-
pears to be a result of LIF de¢ciency in the presence of
slightly higher than normal circulating IGF-I in the
L3=3Iþ=3 mice. Whether the local adipose tissue IGF-I con-
centration is low or high is presently unknown. As re£ected by
the weight gain curves, the phenotype in our study was mark-
edly in£uenced by the sex of the mice. Young adult L3=3Iþ=3
female mice are signi¢cantly smaller than the males of the
same genotype, whose growth curves are very similar to the
Lif null mice. Interestingly, it has been demonstrated that
mice de¢cient in liver production of IGF-I display sexual di-
morphism in GH-stimulated postnatal growth, and this e¡ect
was not provoked by gonadal steroids [17].
The fact that preadipocytes secrete LIF and that an antag-
onist of the LIF receptor inhibits adipogenesis in vitro indi-
cates that, in addition to central e¡ects on body weight, LIF
in£uences adipocyte di¡erentiation directly [18]. It was thus
not surprising to ¢nd a slight decrease in lipid droplets in the
Fig. 2. Northern blot analysis of pituitary GH mRNA (n=6^8 ani-
mals per group). 20 Wg/lane total RNA was analyzed. A representa-
tive blot is shown. Relative abundance of GH mRNA was deter-
mined by densitometry, normalized to levels of L-actin mRNA in
the same sample. In females, Iþ=3Lþ=3 demonstrated a 34% increase
and Iþ=3L3=3 a 25% increase of GH mRNA as compared to wild
type mice. In males, Iþ=3Lþ=3 showed a 44% increase and
Iþ=3L3=3 a 55% increase as compared to wild type males.
Fig. 3. Serum leptin in 8 week old male and female mice. The num-
ber of animals is indicated. a and b are comparisons with the equiv-
alent letter; P6 0.05, by Student’s t-test. Lif null females, but not
males, had signi¢cantly higher values than their wild type controls.
Fig. 4. Perigonadal WAT histopathology in male and female mice.
HpE-stained, representative cross-sections are shown. Genotypes in-
dicated apply to each row. Bar, 40 Wm.
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WAT of both male and female L3=3Iþ=þ mice. The apparent
substitution of WAT by BAT, only in the L3=3Iþ=3 females,
was nonetheless unpredicted. This recruitment appears to be
due to the LIF de¢cit which induces increased leptin, further
increased in the LIF null Igf-I haploinsu⁄cient female mice.
Indeed, leptin has been shown to inhibit marrow stromal cell
di¡erentiation to adipocytes [19] and to increase lipolysis in
WAT and BAT [20].
In recent years, the role of leptin has been extended to
many more e¡ects than that of an adipostatic, anti-obesity
hormone [21]. The source of leptin in the WAT-de¢cient mu-
tant mice remains undetermined. Either the increased BAT
deposits [9] or the pancreas [22] may synthesize it. A periph-
eral mechanism of the sexual dimorphism in leptin secretion
by WAT has been reported [23] but no information is avail-
able relative to BAT. While our study leaves many questions
open, it emphasizes that a combinatorial approach must be
taken to unravel the complex physiology of adipose tissue as a
sexually dimorphic endocrine tissue. Novel LIF and IGF-I
central and local interrelationships, di¡erent in both sexes,
appear to be important modulators of leptin control and the
¢ne equilibrium of body weight.
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